Destiny Parma (DEST.L): Collaboration to develop a COVID-19 treatment | Avacta (AVCT.L): Planned launch of lab-based test for the detection of COVID-19 | ValiRx (VAL.L): Half-year report
07 Sep 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
- Published:
07 Sep 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Destiny Parma (DEST.L): Collaboration to develop a COVID-19 treatment | Avacta (AVCT.L): Planned launch of lab-based test for the detection of COVID-19 | ValiRx (VAL.L): Half-year report